HIVMicrobiome
Meeting category
Date(s)
17 Nov 2016 - 18 Nov 2016
Location
Bethesda, United States
Organizer
Platinum Level Support
Sponsor logos
ViiW

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 17 November 2016

Welcome -
Key note: Systems Biology, Modeling, and Cross-Meta-Omic Analysis of the Human Microbiome
Elhanan Borenstein
Elhanan Borenstein, PhD
University of Washington
Session 1: Pathogenesis -
Chairs
Alan Landay, PhD
Rush University Medical Center, United States
Functional Role of Gut Microbiota in Chronic Liver Disease
Gary Wu
Gary Wu, MD
University of Pennsylvania
Lung Microbiome & HIV
Ron Collman
Ron Collman, MD
University of Pennsylvania
Differences in gut microbiota related metabolic pathways between Elite Controllers and HIV-progressors
J. Vesterbacka
#1
Human gut microbial gene richness correlates with HIV infection
Y. Guillén
#2
Session 2: Transmission and Prevention (Microbicides) -
Chairs
Satya Dandekar, PhD
University of California, Davis, United States
Mother to Infant Transmission
Grace Aldrovandi, MD, CM
University of California, Los Angeles, United States
Live Biotherapeutics: How the Vaginal Microbiome Can be Modified to Prevent HIV Infection
Laurel Lagenaur, PhD
NIH, Osel, United States
Cervicovaginal bacteria impact HIV acquisition in young South-African women
C. Gosmann
#3
Session 3: Round table discussion: Steps forward -
The NIH’s human microbiome project
Lita Proctor
Lita Proctor, PhD
National Institute of Health

DAY 2 - Friday, 18 November 2016

Session 4: Comorbidities -
Chairs
Ronald Collman
Ronald Collman, MD
NIH, United States
Role of the Microbiota in the Control of Tissue Immunity
Yasmine Belkaid
Yasmine Belkaid, PhD
National Institute of Health / Division of Intramural Research
The Human Microbiome and Cancer: New Opportunities For Population Studies
Emily Vogtmann
Emily Vogtmann, PhD, MPH
National Institute of Health / National Cancer Institute
Oral microbiota in relation to HIV infection and oral infection in perinatally HIV-infected adolescents
Bruce Paster
Bruce Paster, PhD
The Forsyth Institute
Case Control study of the oral microbiome in HIV uninfected individuals compared to HIV positive individuals before and after HAART
D. Malamud
#4
Session 5: Microbiome & Vaccines -
Chairs
Stacy Carrington-Lawrence, PhD
Stacy Carrington-Lawrence, PhD
NIH, USA
Angela Malaspina
Angela Malaspina, PhD
NIAID/NIH, USA
The “Window of Opportunity”: Harnessing the Pediatric Immune Landscape for Life-Long Vaccine- Elicited Protection
Sallie Permar
Sallie Permar, MD, PhD
Duke University School of Medicine
Influence of the Microbiota on Immune Responses to RhCMV/SIV Vaccines
Dennis Hartigan
Dennis Hartigan-O’Connor, MD, PhD
University of California
The Impact of Age and Diet on the Non-Human Primate Microbiota
Ivona Pandrea
Ivona Pandrea, MD, PhD
University of Pittsburgh
Session 6: Virome and Mycobiome -
Chairs
Stacy Carrington-Lawrence, PhD
Stacy Carrington-Lawrence, PhD
NIH, USA
The Impact of Age and Diet on the Non-Human Primate Microbiota
Ivona Pandrea
Ivona Pandrea MD, PhD
University of Pittsburgh
The Mycobiome and How it Influences Disease
Mahmoud Ghannoum
Mahmoud Ghannoum, PhD, MBA
Case Western University
Enteric virome analysis of non-invasive samples from gorillas by next-generation sequencing and association with SIV infection
M. D’arc
#5
Alterations in the Enteric Microbiome and Virome and Immune Activation among HIV-infected Individuals in Sub-Saharan Africa and the United States
D. Gootenberg
#6